The heart in essential mixed cryoglobulinemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Line 16: | Line 16: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Cardiology]] | [[Category:Cardiology]] |
Revision as of 16:49, 20 August 2012
Cardiology Network |
![]() Discuss The heart in essential mixed cryoglobulinemia further in the WikiDoc Cardiology Network |
Adult Congenital |
---|
Biomarkers |
Cardiac Rehabilitation |
Congestive Heart Failure |
CT Angiography |
Echocardiography |
Electrophysiology |
Cardiology General |
Genetics |
Health Economics |
Hypertension |
Interventional Cardiology |
MRI |
Nuclear Cardiology |
Peripheral Arterial Disease |
Prevention |
Public Policy |
Pulmonary Embolism |
Stable Angina |
Valvular Heart Disease |
Vascular Medicine |
Template:WikiDoc Cardiology News
Overview
Patients with mixed cryoglobulinemia may sustain myocardial infarction but it is often clinically silent, and affects less than 8.5% of these patients. Congestive heart failure may be observed in up to 30% of the patients with essential mixed cryoglobulinemia. In some patients, congestive heart failure and left ventricular dysfunction are reversible and plasmapheresis may hasten recovery.
Pericarditis, mitral insufficiency and/or aortic insufficiency are seen occasionally essential mixed cryoglobulinemia.
References